Cargando…
Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients
BACKGROUND: The presence of significant liver fibrosis in hepatitis B virus (HBV)-infected individuals with persistently normal serum alanine aminotransferase (PNALT) levels is a strong indicator for initiating antiviral therapy. Serum ceruloplasmin (CP) is negatively correlated with liver fibrosis...
Autores principales: | Kang, Na-Ling, Zhang, Jie-Min, Lin, Meng-Xin, Chen, Xu-Dong, Huang, Zu-Xiong, Zhu, Yue-Yong, Liu, Yu-Rui, Zeng, Da-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385565/ https://www.ncbi.nlm.nih.gov/pubmed/32774069 http://dx.doi.org/10.3748/wjg.v26.i27.3952 |
Ejemplares similares
-
Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase
por: Zeng, Da-Wu, et al.
Publicado: (2016) -
Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection
por: Huang, Ling-Ling, et al.
Publicado: (2021) -
Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus
por: Cao, Xi, et al.
Publicado: (2020) -
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
por: Fujimori, Naoyuki, et al.
Publicado: (2018) -
Serum Ceruloplasmin Levels Correlate Negatively with Liver Fibrosis in Males with Chronic Hepatitis B: A New Noninvasive Model for Predicting Liver Fibrosis in HBV-Related Liver Disease
por: Zeng, Da-Wu, et al.
Publicado: (2013)